MBGPFMOBERG PHARMA AB

About MOBERG PHARMA AB (MBGPF)

MOBERG PHARMA AB (MBGPF) is a Drug Manufacturers - Specialty & Generic company headquartered in Bromma, Sweden whose shares trade over-the-counter on the Pink tier.

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.

MBGPF key facts

Ticker symbol

MBGPF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Bromma, Sweden

Country of incorporation

SE

Estimated market cap

$57.44M (as of May 8, 2025)

Shares outstanding

75,871,660

Reporting standard

International Reporting: Nasdaq OMX Nordic Exchange Stockholm

Audit status

Audited

Fiscal year end

12/31

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with M